Latest S-1 registration statements

Quantum Computing Inc. has filed an S-1 registration statement to allow selling stockholders to resell up to 14,035,089 shares of common stock, which were recently issued in a private placement that generated approximately $200 million in gross proceeds for the company.

Ambiq Micro, a pioneer in ultra-low power semiconductor solutions for edge AI, has filed for an initial public offering to fund its growth strategy, despite a history of net losses and significant customer concentration.

General Enterprise Ventures, Inc. (GEVI) is pursuing a public offering of 1,250,000 common shares at an assumed price of $12.00 per share to raise approximately $15 million, contingent on listing its environmentally sustainable fire retardant product on NYSE American.

Reliance Global Group, Inc. filed an Amendment No. 1 to its S-1 Registration Statement to include previously omitted exhibits and register up to 4,568,455 shares of common stock for resale by selling stockholders.

Xcel Brands, Inc. is launching a best-efforts public offering of up to 1,381,215 shares of common stock and pre-funded warrants to raise approximately $1.9 million in net proceeds, while navigating significant debt obligations and a strategic reduction in its IM Topco LLC equity interest.

Entero Therapeutics, Inc. is seeking to raise approximately $4 million through a public offering of common stock and pre-funded warrants to fund operations and advance its lead drug candidate, Adrulipase, while navigating severe financial constraints and the rescission of a recent merger.

DevvStream Corp., a newly public environmental asset generation company, reported substantial net losses and a critical working capital deficit, triggering a Nasdaq minimum bid price non-compliance notice, while actively seeking significant capital to fund its operations and strategic initiatives.

First Choice Healthcare Solutions, Inc. is undergoing a significant strategic transformation, shifting from its legacy orthopedic business to a national network of primary care and wellness clinics, supported by a new public offering of Series D Convertible Preferred Stock and warrants aiming to raise $10 million.

Healthy Choice Wellness Corp. has filed an S-1 registration statement for the resale of 2,355,072 shares of Class A common stock, signaling a move to enhance liquidity for selling stockholders while the company continues to expand its natural grocery and wellness footprint.

RYVYL Inc. is offering up to $8 million in securities to address severe liquidity issues and Nasdaq non-compliance, following a significant 70-80% revenue reduction from the sale of its European subsidiary and challenges with its core North American product.

FG Merger III Corp., a blank check company, filed an amended S-1 registration statement for an initial public offering of 20,000,000 units at $10.00 each, targeting the North American financial services industry for its initial business combination.

ZyVersa Therapeutics, a clinical-stage biopharmaceutical company, has entered into an equity purchase agreement to raise up to $10 million, while simultaneously facing substantial doubt about its ability to continue as a going concern and ongoing Nasdaq listing compliance challenges.

EQV Ventures Acquisition Corp. II has filed a Rule 462(b) registration statement to offer an additional 8,050,000 units, each consisting of one Class A ordinary share and one-third of one redeemable warrant, expanding its initial public offering.

BRB Foods Inc., a Brazilian dry food manufacturer, filed an S-1/A for its initial public offering, seeking to raise $16.875 million to fund a strategic relaunch of 61 new products by Q3 2025, despite recent net losses and a temporary suspension of product sales.

Figma, Inc. has filed its S-1 registration statement for an initial public offering, showcasing robust revenue growth and an expanded AI-powered product suite, despite a 2024 net loss driven by one-time equity compensation events.

Scientific Industries, Inc. has filed an S-1/A registration statement for the resale of up to 3.1 million shares of common stock by selling stockholders, while reporting continued net losses and acknowledging substantial doubt about its ability to continue as a going concern.

Curanex Pharmaceuticals Inc., a developmental stage company focused on botanical drugs for inflammatory diseases, has filed an S-1/A amendment for its initial public offering to raise up to $15 million, while also extending the maturity date of a significant related-party promissory note.

Scientific Industries, Inc. has filed an S-1 registration statement for the resale of 3.1 million shares by existing stockholders, revealing continued operating losses, a significant accumulated deficit, and a stated need for additional capital to fund its bioprocessing growth initiatives.

DevvStream Corp., an environmental asset generation company, reported substantial net losses and a working capital deficit, raising significant doubt about its ability to continue as a going concern, while also facing a Nasdaq minimum bid price compliance issue following its November 2024 business combination.

McKinley Acquisition Corporation, a newly formed blank check company, has filed an S-1 registration statement for a $150 million initial public offering, aiming to acquire businesses in progressive industries like fintech, cleantech, and AI with enterprise values between $500 million and $2 billion.

Accelerant Holdings, a specialty insurance marketplace, has filed a registration statement with the SEC for its proposed initial public offering (IPO).

Currenc Group Inc. reported a substantial increase in net loss and working capital deficit for the three months ended March 31, 2025, alongside receiving Nasdaq deficiency notices, highlighting severe financial and operational challenges despite strategic shifts towards AI and divestitures.

Mullen Automotive Inc. has filed an amended registration statement to allow selling stockholders to resell up to 40 million shares, signaling substantial potential dilution for existing shareholders and ongoing struggles with Nasdaq listing compliance.

Athena Bitcoin Global reported a significant decrease in Q1 2025 revenue and net income, primarily due to market uncertainty and reduced transaction sizes, while continuing its global ATM network expansion and facing multiple class-action lawsuits.

MSM Frontier Capital Acquisition Corp., a blank check company, filed an S-1/A for a $225 million initial public offering to pursue business combinations in Africa's infrastructure sector, focusing on power, oil & gas, and cement.

Oragenics, Inc. has filed an amendment to its registration statement to facilitate a new securities offering, aiming to raise at least $15 million in gross proceeds to address its immediate liquidity needs and mitigate substantial doubt about its ability to continue as a going concern beyond Q3 2025.

Cellectar Biosciences, a late-stage clinical biopharmaceutical company, has filed an S-1/A registration statement for a public offering of up to 755,667 Class A or Class B Units to raise approximately $5.0 million, primarily to advance its cancer drug pipeline, despite facing significant financial constraints and a recent reverse stock split.

D. Boral ARC Acquisition II Corp., a newly formed blank check company, has filed an S-1 registration statement for an initial public offering of 25 million units at $10.00 each, aiming to raise $250 million for a business combination with an enterprise value of $700 million or greater.

D. Boral ARC Acquisition I Corp. filed an S-1/A for its initial public offering of 25 million units at $10.00 each, aiming to acquire a business with an enterprise value of $700 million or greater.

A Paradise Acquisition Corp., a British Virgin Islands-based blank check company, has filed an amended S-1 registration statement detailing its $200 million initial public offering, its search for a leisure and entertainment sector target, and significant risks associated with its SPAC structure and potential business combinations in China.